Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Early hair loss may predict heart disease.

Rogaine can stop hair loss in women, and other treatments like certain pills, light therapy, and special shampoos may also work.

Genetic factors could lead to personalized treatments for hair loss.

Obesity and bariatric surgery can cause hair thinning and temporary hair loss due to nutritional deficiencies and stress.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Hair proteins in preschool children and their mothers could indicate developmental changes and health status.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

Not getting enough minerals can lead to health problems and shorter lifespans.

Melampus might have cured Proetus' daughters, who possibly had ergotism or Cushing's syndrome, using the herb Helleborus niger, but a mix of factors could have caused their symptoms.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Spironolactone is useful for treating acne and other skin conditions like excessive hair growth and certain types of hair loss.

Doctors are prescribing spironolactone more often to treat acne and skin conditions in teenagers, and it seems safe and well-tolerated.

Spironolactone may be effective for acne and other skin conditions and could be used more in treatment.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Diuretics can cause serious side effects and should be used carefully.

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.